SOUTH SAN FRANCISCO, Calif. (AP) _ Lyell Immunopharma Inc. (LYEL) on Tuesday reported a loss of $68.1 million in its first quarter.

The South San Francisco, California-based company said it had a loss of 28 cents per share.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 27 cents per share.

The biotechnology firm posted revenue of $553,000 in the period.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LYEL at https://www.zacks.com/ap/LYEL

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News